SMLR.Semler Scientific, INC

SCHEDULE: Capital International Investors Discloses 2.6% Stake in Semler Scientific

Sentiment:

Institutional Ownership Disclosure

📋All filings for Semler Scientific, INC
🔒Login to Follow

Capital International Investors has reported a 2.6% beneficial ownership stake in Semler Scientific, Inc. as of September 30, 2025.

Summary

  • Capital International Investors (CII) filed an Amendment No. 1 to Schedule 13G regarding its ownership in Semler Scientific, Inc.
  • CII beneficially owns 385,239 shares of Semler Scientific's Common Stock.
  • This ownership represents 2.6% of the 14,804,693 shares believed to be outstanding.
  • CII holds sole voting power and sole dispositive power over all 385,239 shares.
  • The securities were acquired and are held in the ordinary course of business, not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: Neutral, as this is a routine ownership disclosure. The presence of an institutional investor is generally a minor positive, but the filing itself provides no operational or financial news.

Positives

  • A significant institutional investor, Capital International Investors, holds a stake in Semler Scientific, indicating potential confidence in the company.
  • The holding is for investment purposes in the ordinary course of business, not for activist intentions.

Future Outlook

NA

Industry Context

NA

Stakeholder Impact

  • Shareholders: Provides transparency on significant institutional holdings, potentially signaling investor confidence.

Key Dates

DateDescription
09/30/2025Date of event requiring the filing of this statement.
11/13/2025Date the Schedule 13G/A was signed by Capital International Investors.

Recommendation

hold

This Schedule 13G filing is a routine disclosure of institutional ownership by Capital International Investors, indicating a 2.6% stake in Semler Scientific. It does not contain any operational, financial, or strategic information about Semler Scientific that would warrant a change in investment recommendation. The holding is stated to be in the ordinary course of business, not for control purposes. Therefore, based solely on this filing, a 'hold' recommendation is appropriate as there's no new information to alter an existing investment thesis.

Keywords

Semler Scientific, Capital International Investors, Schedule 13G, Institutional Ownership, Common Stock, Investment Adviser, Shareholding Disclosure

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.